Company Filing History:
Years Active: 2018
Title: Bo Young Jeong: Innovator in Dual-Target Antibody Development
Introduction
Bo Young Jeong is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of dual-target antibodies. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Bo Young Jeong holds 2 patents, with his latest inventions focusing on a dual-target antibody that targets VEGFR-2 and DLL4. This novel form of the dual-target antibody is designed to improve therapeutic outcomes in various medical applications. The patent details a gene encoding the antibody, a recombinant expression vector, and host cells transformed with this vector. Additionally, it outlines a method for producing the dual-target antibody and a pharmaceutical composition that includes the antibody.
Career Highlights
Throughout his career, Bo Young Jeong has been associated with Pharmabcine Inc., where he has played a crucial role in research and development. His work has not only contributed to the company's portfolio but has also advanced the field of antibody therapeutics.
Collaborations
Bo Young Jeong collaborates with talented individuals such as Joong Kyu Kim and Jin San Yoo, who contribute to the innovative projects at Pharmabcine Inc. Their teamwork fosters a creative environment that enhances the development of groundbreaking medical solutions.
Conclusion
Bo Young Jeong's contributions to the field of biotechnology, particularly through his dual-target antibody inventions, highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.